SCHEMBL1090653

SCHEMBL1090653

c1ccc(CCNc2nc(N3CCc4ccccc4C3)c3ccccc3n2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 1/20 0.61
APP P05067 5/20 0.55
HRH4 Q9H3N8 4/20 0.51
HRH1 P35367 2/20 0.51
GBA1 P04062 1/20 0.50
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
GRIN2C Q14957 1/20 0.49
GRIN3A Q8TCU5 1/20 0.49
BCHE P06276 4/20 0.48
ACHE P22303 4/20 0.48
KDM6B O15054 3/20 0.46
SLC2A1 P11166 1/20 0.45
ADRA2B P18089 1/20 0.43
ADRA2C P18825 1/20 0.43
SLC6A2 P23975 1/20 0.43
HRH2 P25021 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090896 0.90 GBA1 (0.53) MRGPRX1APPHRH4HRH1GBA1
SCHEMBL1091263 0.86 GBA1 (0.48) MRGPRX1APPGBA1GRIN2DGRIN3B
SCHEMBL1089853 0.84 MRGPRX1 (0.51) MRGPRX1GBA1GRIN2DGRIN3BGRIN1
SCHEMBL2947363 0.84 ADAMTS4 (0.51) MRGPRX1GBA1GRIN2DGRIN3BGRIN1
SCHEMBL1091226 0.84 GBA1 (0.48) MRGPRX1GBA1GRIN2DGRIN3BGRIN1
SCHEMBL1089123 0.84 MRGPRX1 (0.50) MRGPRX1HRH1GBA1GRIN2DGRIN3B
SCHEMBL1090661 0.83 MRGPRX1 (0.84) MRGPRX1APPHRH4BCHEACHE
SCHEMBL2955070 0.83 KDM1A (0.49) MRGPRX1HRH1GBA1GRIN2DGRIN3B
SCHEMBL2945982 0.83 GBA1 (0.47) MRGPRX1GBA1GRIN2DGRIN3BGRIN1
SCHEMBL1091393 0.83 HRH3 (0.54) MRGPRX1HRH1GBA1GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885APP 1377/4885HRH4 130/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885APP 1377/4885HRH4 130/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885APP 1377/4885HRH4 130/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.